Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology
NCT ID: NCT06366581
Last Updated: 2024-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2023-03-01
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective Analysis of Incisional Hernia Repair's Postoperative Recurrence
NCT06102551
Incisional Hernia Progression Over Time
NCT02616718
Clinical Study of Hernia Ring Closure Method in Laparoscopic Abdominal Wall Hernia Repair
NCT05661097
Hernia After Colorectal Cancer Surgery
NCT03390764
Suture Repair vs Mesh Repair in the Treatment of Incarcerated Groin Hernia in Elderly Populations
NCT05966285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IH group
Patients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group)
Transcriptomic analysis
high-throughput sequencing technology
NC group
patients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group)
Transcriptomic analysis
high-throughput sequencing technology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcriptomic analysis
high-throughput sequencing technology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. malignant tumors not been completely relieved by active treatment,
3. patients who have psychiatric diseases or comprehension disorders.
4. patients with metabolic disease involving connective tissue collagen.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhijun Bao
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hua Dong Hospital Affiliated to Fu Dan University
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HD20240307
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.